TEDA BIOMEDICAL (08189) has signed a strategic cooperation framework agreement with Xingchen General to jointly promote the formation and industrialization of a medical health embodied intelligence technology system, product system, and solutions.

TEDA BIOMEDICAL (08189) announced that the company has signed a strategic cooperation framework agreement with Hunan Xingchen General Siasun Robot & Automation Co., Ltd. (Xingchen General). The two parties will adhere to the principles of equality, voluntariness, complementary advantages, scenario-driven collaboration, joint innovation, resource sharing, and long-term cooperation. They will work together to promote the deep integration of medical health large models and embodied intelligence technology, aiming to establish and industrialize a system, product, and solution for medical health embodied intelligence technology. The board of directors believes that the integration of medical health large models and embodied intelligence technology is a significant direction for advancing artificial intelligence from information understanding, knowledge questioning, and decision support to real-world perception, physical interaction, and task execution. The company has long been engaged in business layout around medical health technology, medical intelligence applications, and related industries. It has the capabilities for research, development, operation, and continuous updating and iteration of medical health large models, medical vertical intelligent agents, medical knowledge systems, and related algorithms, enabling it to leverage professional knowledge, business processes, service demands, and application scenarios in the medical health field, thus facilitating the applications of medical health large models and intelligent agents in health consultation, navigation and diagnosis, health management, elderly care and rehabilitation, public health, medical institution operations, and other relevant scenarios. Xingchen General is a high-tech enterprise centered on the development of embodied intelligence full-stack technology and the Siasun Robot & Automation hardware core. It is building an embodied intelligence "one brain, multiple bodies" Siasun Robot & Automation technology ecosystem and possesses capabilities in Siasun Robot & Automation ontology, intelligent hardware, edge intelligent systems, multi-sensor fusion, navigation, positioning, motion control, Siasun Robot & Automation skill development, product engineering, and scenario delivery, enabling it to promote the deep integration of models and intelligent agents with Siasun Robot & Automation terminals, completing perception, interaction, movement, and task execution in real environments. There is strong complementarity between the two parties in these fields. Through this strategic cooperation, the company can deeply integrate its core capabilities in medical health large models, vertical intelligent agents, and medical knowledge systems with Xingchen General's embodied intelligence Siasun Robot & Automation, intelligent hardware, and scenario delivery capabilities. Together, they will create a medical health embodied intelligence technology system, product system, and solution, establishing a closed loop of medical health embodied intelligence encompassing "data collection and governance - model and intelligent agent R&D - terminal adaptation - pilot verification - scenario application - operational feedback - continuous iteration - industrial promotion." On one hand, this will help promote the extension of medical health large models and intelligent agents from digital spaces into the real physical world, accelerating the large-scale application of quality projects in hospitals, grassroots medical facilities, community health, elderly care and rehabilitation, family health, public health, and other scenarios. On the other hand, it will also help further expand the group's business scope in AI healthcare, medical health large models, and embodied intelligence, enhancing the groups technical strength, product competitiveness, and market influence in the field of medical health artificial intelligence, thus laying a solid foundation for the group's long-term high-quality development.